Skip to main content

Glaxo pulls the plug on resveratrol drug: end of the line?

Resveratrol, the antioxidant molecule from red wine (along with miniscule amounts from some berries and the non-edible parts of the peanut plant), took the world by storm a few years back when it was announced that it could trigger a specific metabolic change associated with significant lifespan extension. Though the phenomenon was only found at first in some strains of yeast under certain conditions, it was believed to work by activating an enzyme system known as sirtuins, which in turn control the switching on and off of genes associated with longevity and a range of diseases of aging. The potential for resveratrol-based compounds caught the attention of pharma giant GlaxoSmithKline, which acquired the rights to it for US $720 million in 2008. But this week Glaxo announced the suspension of all development of their product, known as SRT501, citing concerns about complications in a clinical trial for the blood cancer multiple myeloma. Many now wonder whether resveratrol has gone from darling to dud in only 2 short years.

Meanwhile, sales of resveratrol supplements, based on the naturally occurring and non-patentable molecule, have soared in recent years. Purveyors openly tout it as a “fountain of youth in a pill” and a miracle weight loss solution. Some advocates of natural healing are openly celebrating Glaxo’s failure, accusing them of greedily hijacking a perfectly good natural cure in the name of corporate greed by developing synthetic (and patentable) variations. Pfizer and Amgen have both weighed in recently with scientific publications casting doubt on the ability of resveratrol and its derivatives to activate sirtuins at all, pointing to evidence that the testing method was an artifact leading to false positive results. Is this the end of the road for resveratrol?

There’s support for both arguments, but don’t mark your calendars just yet for resveratrol’s funeral. For one, the natural molecule has a wide range of interesting capabilities, at least in lab studies. Clinical trials are ongoing and much remains to be learned about whether this translates to verifiable benefits in humans. (One thing that appears unlikely is the lifespan extension phenomenon via sirtuin activation, as it has not been found in mammals.) Glaxo was careful to point out that other resveratrol derivatives are being studied, and the point of synthesizing variations on the molecule is to find more potent versions with specifically targeted actions. (See the full quote below.) And without the prospect of return on investment, there is little funding available for studying the natural version. Until more results are in, my suggestion is to bear in mind that the whole thing started with red wine, which does confer longer life on average for moderate regular consumers, along with higher quality of life.

From Glaxo: ”We are focusing our efforts now on more selective SIRT1 activator compounds that have no chemical relationship to SRT501 and more favorable drug-like properties. Currently we have two of these latest generation compounds (SRT2104 and SRT2379) in several exploratory clinical trials.”


Popular posts from this blog

Wear red and DRINK red for women’s heart health

This Friday Feb 2nd is the annual “wear red” day in Canada and the U.S. to raise awareness for women’s heart health. Why only a day for the number one threat to women’s health? Women are 5 times more likely to succumb to heart disease than breast cancer, which gets a whole month (October.) Another contradiction is that the advice women hear about prevention of breast cancer is the opposite of what you can do to lower the risk of heart disease: a daily glass of wine. Even one drink a day raises your risk of breast cancer, we are told, ignoring the overriding benefits of wine on heart health. Drink red wine to live longer Here’s why I think women should also “drink red.” For starters, wine helps de-stress and celebrates life. Stress is a factor in heart disease, and if that were the only way wine helped it would be worth considering. But the medical evidence is also strong: a daily glass of red wine helps raise the HDL “good cholesterol” levels, which lowers the risk of cardiovascular p…

How globalization of drinking habits threatens the French paradox

It seems that the more studies we see on the relationship between wine and health, and the larger they are, the more contradictory the results. Headlines summarizing comprehensive international studies declare the French paradox dead, and all alcoholic beverages are equally detrimental. I think there is an overlooked explanation for this: over the past several decades, convergence of drinking patterns around the world has separated wine from its role as a daily part of a meal. Globalization has commoditized our views about drink, toppling it from its role as a culturally specific emblem. Global convergence of drinking There are several recent reports summarizing the trend,[i],[ii],[iii]and it applies for both developed and developing countries. Since the early 1960s, wine’s share of global alcohol consumption has more than halved, declining from 35% to 15%. Beer and spirits have taken up the slack, with beer gaining 42% and spirits adding 43%, both large gains. The bigger story howeve…

Which types of wine are the healthiest?

I am often asked after lecturing on the healthful properties of wine which type is best to drink. Since much of the discussion has to do with the polyphenol antioxidants from the skins and seeds of the grape, red wine is the first criterion since it is fermented with the whole grape rather than the pressed juice. This allows for extraction and concentration of these compounds, familiar ones being resveratrol and tannins. But beyond that, which varietals have the highest concentrations?

According to the Roman philosopher Pliny the Elder, “The best kind of wine is that which is pleasant to him that drinks it” but modern science expects more specifics. (The point of course is that if you have a wine that you enjoy you are more likely to drink regularly and therefore reap the benefits.) But there are several difficulties in singling out certain wines for their healthful properties. Which compounds to measure? Are we talking about heart health or the whole gamut? Is it the varietal of the …